A fortune favors bold peptide policymaking
The peptide business is already roughly as big as legal weed. Just saying.
The power of Federalism always has been about different parts of the country experimenting with ways of running their hunk of freedom-loving land.
The FDA recently sent letters1 out to multiple providers of peptides in the U.S. warning them that further action could be taken if they don’t quit offering what they call ““new d…